Experimental Drug CBL-514 Destroys Visceral Fat, Offering New Hope for Metabolic Health
A new experimental drug, CBL-514, has shown promise in eliminating dangerous visceral fat, unlike traditional weight loss methods that only shrink fat cells. Early trials indicate a significant reduction in fat surrounding internal organs, potentially mitigating risks for diabetes and heart disease.